Period
recent search
Showing: 1 – 05 of 156 Regulated Information
Share buyback program – Ipsen reporting from 25 July to 29 July 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
Ipsen delivers strong H1 2022 results and upgrades its full-year guidance
Paris (France), 28 July 2022 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, presents its financial results for the first half of 2022:
Ipsen publishes its 2022 half year financial report
This article or press release has no online content. Please download the associated documents for more information.
Share buyback program – Ipsen reporting from 18 July to 22 July 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
Share buyback program – Ipsen reporting from 11 July to 15 July 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
